Clene Inc.
Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of therapeutics for neurodegenerative diseases. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded on August 12, 2020 and is headquartered in Salt Lake City, UT.
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/tronc/2XWTZZQLK5A6XLZ3X2KE34J2K4.jpg)
